Hepatic ischemia and reperfusion (IR) is a frequent cause of acute liver failure during the perioperative period. Patients suffer from hepatic IR in many clinical conditions including liver transplantation, major hepatic resection or prolonged portal vein occlusion. 1, 2 The pathophysiology of hepatic IR injury is complex and both hepatic (hepatocytes, Kupffer cells) and extra-hepatic (leukocytes, circulating cytokines) factors have important roles. Hepatic IR frequently leads to remote organ injury including kidney, lung, and heart. 3, 4 In particular, acute kidney injury (AKI) or hepatorenal syndrome occurs frequently in patients with acute liver failure (40-85% incidence) and the development of AKI after liver injury greatly increases mortality and morbidity during the perioperative period by potentiating extrarenal organ injury including liver. 5, 6 Therefore, injury of one organ (liver or kidney) can cause and potentiate injuries in both organs. We recently developed a murine model of liver IR-induced AKI characterized by early renal endothelial cell apoptosis, proximal tubule inflammation (because of cytokine and neutrophil infiltration), and necrosis. 7 Liver IR-induced AKI also produced severe impairment in vascular permeability together with filamentous (F)-actin degradation of kidney. 7 Therefore, AKI developed because of liver IR seems to be a disease of early renal endothelial cell apoptosis and dysfunction with subsequent F-actin degradation and proximal tubular necrosis/inflammation.
Our laboratory previously showed that exogenous and endogenous A 1 adenosine receptor (A 1 AR) activation protected against renal IR injury in mice 8, 9 as well as in rats 10, 11 with reduced renal tubular necrosis, apoptosis, and inflammation. Moreover, endogenous A 1 ARs have an important role in protecting the liver against IR injury in mice. 12 Therefore, endogenous and exogenous activation of A 1 ARs protect against renal as well as hepatic IR injury. We also showed that injection of lentivirus encoding for human A 1 ARs (huA 1 AR) resulted in a selective expression in the injected kidney and this selective renal expression of A 1 ARs attenuated renal IR injury in mice lacking A 1 ARs. 13 Therefore, we tested the following hypothesis in this study: overexpression of huA 1 ARs in the kidney would protect against AKI after hepatic IR. We questioned whether (1) selective unilateral overexpression of renal A 1 ARs in mice through viral gene delivery would increase the resistance against hepatic IR-induced AKI in mice and (2) protecting the kidney would result in reduced liver injury after severe hepatic IR injury.
We used intrarenal gene delivery with a lentiviral vector that expresses either enhanced green fluorescent protein (EGFP) or EGFP-huA 1 AR. We subsequently probed for the expression of transgene in the injected kidney and in the liver. We also subjected mice to liver IR injury 48 h after unilateral renal injection with lentivirus encoding EGFP or EGFPhuA 1 AR. Finally, we probed the mechanisms of renal protection with EGFP-huA 1 AR overexpression by examining whether renal huA 1 AR overexpression in mice leads to HSP27 upregulation in the injected kidney. We demonstrate that mice renally injected with EGFP-huA 1 AR lentivirus showed (1) significant renal protection after hepatic IR injury with reduced necrosis, inflammation, and renal endothelial cell apoptosis when compared with mice injected with EGFP lentivirus; (2) markedly improved liver function and reduced liver necrosis, apoptosis, and inflammation after liver IR; and (3) upregulation of HSP27 and increased colocalization with huA 1 ARs in kidneys injected with EGFP-huA 1 AR lentivirus. Therefore, selective unilateral overexpression of A 1 ARs in mice through lentiviral delivery protected against both acute liver failure and AKI after liver IR in vivo.
METHODS
Detailed methods describing surgery and anesthesia protocols, immunohistochemistry, and RNA isolation are available as Supplementary information.
Intrarenal Lentivirus Delivery In Vivo
Lentivirus encoding EGFP or EGFP-huA 1 AR was generated as described previously 14, 15 (Supplementary information). In vivo virus transduction to express huA 1 ARs in kidneys of mice was performed as described by Nakamura et al 16 with slight modifications as described previously 13 (Supplementary information).
Determination of Transgene Expression with Intrarenal Lentivirus Injection
We used three techniques to detect the expression of EGFP or EGFP-huA 1 AR in kidney and liver after intrarenal injection of lentivirus. The following are the three techniques: (1) direct visualization of EGFP in frozen sections, (2) immunohistochemistry for huA 1 ARs, and (3) RT-PCR for the EGFP-A 1 AR transgene in liver and kidney tissues. Fortyeight hours after lentivirus injection, kidneys and livers were removed, embedded in Tissue-Tek oxytetracycline compound (Fisher Scientific, Suwanee, GA, USA) in dry ice and were cut into 5 mm sections. EGFP expression was directly visualized with a fluorescence microscope (Olympus IX81, Tokyo, Japan), and the images were captured and stored using SlideBook 4.2 software (Intelligent Imaging Innovations, Denver, CO, USA) on a personal computer. Immunohistochemistry for huA 1 ARs was performed as described below. Finally, total RNA was extracted from renal cortices or liver and we performed reverse transcription-PCR assays for EGFP-huA 1 AR, EGFP and mouse GAPDH as described previously 14, 17, 18 (Table 1) . The EGFP-huA 1 AR primer was designed with a sense primer that would anneal in the extreme 5 0 end of the A 1 AR portion of the construct, whereas the anti-sense primer anneals to the extreme 3 0 end of the EGFP portion.
We previously showed that activation and overexpression of A 1 ARs led to upregulation of HSP27 expression. 13, 14 Therefore, we also determined whether overexpression of huA 1 ARs through lentiviral gene delivery resulted in upregulation of mouse HSP27 mRNA expression in the injected kidney with RT-PCR as described previously. 14 We also determined whether the contralateral kidney or liver HSP27 mRNA expression changes after unilateral renal injection of EGFP-huA 1 AR lentivirus.
Murine Model of Hepatic IR All protocols were approved by the Institutional Animal Care and Use Committee of Columbia University. Two days after intrarenal injection of lentivirus encoding EGFP or EGFPhuA 1 AR into the left kidney, male C57BL/6 mice (20-25 g; Harlan, Indianapolis, IN, USA) were subjected to liver IR injury as described previously 7 (Supplementary information). Sham-operated mice were subjected to laparotomy and identical liver manipulations without the vascular occlusion. In some mice, we removed the EGFP or EGFP-huA 1 AR lentivirus-injected left kidney before liver ischemia to determine whether the EGFP-huA 1 AR overexpressing kidneys are directly responsible for reducing liver and kidney injury after liver IRI.
Twenty-four hours after reperfusion, the liver tissue subjected to IR and kidneys were collected to measure necrosis, neutrophil infiltration (with immunohistochemistry), vascular permeability, apoptosis (with terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling staining, DNA laddering, and caspase 3 protein cleavage), and F-actin integrity. In some mice, liver and kidneys were collected 5 h after reperfusion to detect inflammatory changes by RT-PCR for proinflammatory cytokine mRNAs. We also collected plasma for the measurement of alanine aminotransferase (ALT) and creatinine at 5 and 24 h after reperfusion.
Plasma ALT Activity and Creatinine Level
The plasma ALT activities were measured using the Infinity TM ALT assay kit according to the manufacturer's instructions (Thermo Fisher Scientific, Waltham, MA, USA). Plasma creatinine was measured by an enzymatic creatinine reagent kit according to the manufacturer's instructions (Thermo Fisher Scientific). This method of creatinine measurement largely eliminates the interferences from mouse plasma chromagens well known to the Jaffe method. 19 Histological Analysis of Hepatic and Renal Injury For histological preparations, liver or kidney tissues were fixed in 10% formalin solution overnight. After automated dehydration through a graded alcohol series, transverse liver slices were embedded in paraffin, sectioned at 4 mm, and stained with hematoxylin and eosin (H&E). Liver H&E sections were graded for IR injury by a pathologist (VDD) who was blinded to the samples using the system devised by Suzuki et al. 20 In this classification, three liver injury indices are graded: sinusoidal congestion (0-4), hepatocyte necrosis (0-4), and ballooning degeneration (0-4) are graded for a total score of 0-12. No necrosis, congestion, or centrilobular ballooning is given a score of 0 whereas severe congestion/ ballooning and 460% lobular necrosis are each given a value of 4. Renal H&E sections were evaluated for the severity (score: 0-3) of renal cortical vacuolization, peritubular/ proximal tubule leukocyte infiltration, percentage of proximal tubule simplification and proximal tubule hypereosinophilia by an experienced pathologist (VDD) who was blinded to the treatment each animal had received.
Enzyme Linked Immunosorbent Assay For Plasma, Liver and Kidney TNF-a MCP-1 and ICAM-1 After 5 and 24 h of liver reperfusion, the plasma, liver, and lentivirus-injected kidney tissue TNF-a, MCP-1, and ICAM-1 levels were measured with mouse specific ELISA kits according to the manufacturer's instructions (eBiosciences, San Diego, CA, USA). We also measured plasma cytokine levels in mice subjected to nephrectomy of the lentivirusinjected kidney and hepatic ischemia and 24 h reperfusion. Liver and kidney tissues were homogenized in ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, and 1% Triton-X (pH 7.4)) and samples processed for mouse specific ELISA kits.
Assessment of Liver and Kidney Inflammation
Liver and kidney inflammation after hepatic ischemia was determined by the detection of neutrophil infiltration by immunohistochemistry 24 h after hepatic IR as described previously 7 and by measuring mRNA encoding markers of inflammation, including keratinocyte-derived cytokine (KC), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractive protein-1 (MCP-1), macrophage inflammatory protein-2 (MIP-2), and TNF-a 5 h after liver IR as described 7 (Supplementary information).
Kidney and Liver Tissue Immunoblotting Analyses for HSP27 and b-Actin Forty-eight hours after lentivirus injection, liver tissues or mouse kidney tissues (lentivirus-injected left kidney and contralateral right kidney) were dissected on ice and immediately placed in ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, 1 mM EDTA, and 1% Triton-X (pH 7.4)) and homogenized for 10 s on ice. The samples were centrifuged for 30 min at 50 000 g. The supernatant was collected and used for immunoblotting of mouse HSP27 (primary antibody from Millipore, Billerica, MA, USA) and b-actin (primary antibody from Sigma, St Louis, MO, USA, as protein loading control) as described previously. 7, 14 Vascular Permeability of Liver and Kidney Tissues Changes in liver and kidney vascular permeability were assessed by quantitating extravasation of Evans blue dye (EBD) into the tissue as described by Awad et al 21 with some modifications as described 22 (Supplementary information).
Detection of Liver and Kidney Apoptosis
We used three independent assays to assess the degree of liver and kidney apoptosis after IR: in situ Terminal Deoxynucleotidyl Transferase Biotin-dUTP Nick End-Labeling (TUNEL) assay, detection of DNA laddering, and immunoblotting for fragmented caspase 3 as describe previously 7, 14 (Supplementary information). For DNA laddering, liver and kidney tissues were removed 24 h after liver IR, apoptotic DNA fragments were extracted according to the methods of Herrmann et al. 23 This method of DNA extraction selectively isolates apoptotic, fragmented DNA and leaves behind the intact chromatin. We also performed b-actin immunoblotting to confirm equal protein loading in our caspase 3 immunoblotting experiments.
F-Actin Staining of Liver and Kidney Sections
As breakdown of F-actin occurs early after IR, we visualized the F-actin cytoskeleton by staining with phalloidin as an early index of liver as well as renal injury 24 as described previously 22 (Supplementary information).
Immunohistochemistry for HSP27 and huA 1 AR Forty-eight hours after intrarenal lentivirus injection, immunohistochemistry for murine HSP27 and huA 1 AR were performed as described previously 13 (Supplementary information).
Protein Determination
Protein contents were determined with a bicinchoninic acid protein assay kit (Pierce Chemical, Rockford, IL, USA), using bovine serum albumin as a standard.
Statistical Analysis
The data were analyzed with t-test when means between two groups were compared or with one-way (eg, plasma creatinine or ALT) ANOVA and Tukey's post hoc multiple comparison test to compare mean values across multiple treatment groups. In all cases, Po0.05 was taken to indicate significance. All data are expressed as mean ± s.e.m.
Reagents
Unless otherwise specified, all chemicals were obtained from Sigma.
RESULTS

Selective
In Vivo Renal Expression of EGFP or EGFP-huA 1 AR after Intrarenal Lentiviral Gene Delivery in Mice None of the mice died or showed signs of AKI after lentiviral injection to their kidneys. We first determined in this study that selective intrarenal injection of lentivirus produced robust expression of the transgene in the injected kidney without significant expression in the right kidney or in the liver. Figure 1a shows that intrarenal delivery of lentivirus encoding EGFP or EGFP-huA 1 AR resulted in a robust and selective expression of transgene in the renal cortical areas (cortex and corticomedullary junction) of the injected kidneys. The transgene expression was very low in the medulla (concentration of collecting ducts and thin limbs of Henle) of injected kidneys. Furthermore, predominant membrane/ cytosolic (green) localization but not nuclear (dark) expression of EGFP-huA 1 AR was observed after lentivirus injection. In the liver (Figure 1b ), the transgene expression was undetectable (similar to baseline green auto-fluorescence) 48 h after lentiviral injection into the left kidney. Moreover, we failed to observe green fluorescence in the contralateral kidney (Figure 1a ), heart or lungs (not shown) of mice renally injected with lentiviruses encoding these constructs. We also confirmed the expression of huA 1 ARs in EGFPhuA 1 AR renally injected mice by performing immunohistochemistry with an antibody specific for huA 1 ARs. Figure 3 ).
Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus Reduces TNF-a, MCP-1, and ICAM-1 Levels in Plasma, Liver, and Lentivirus-Injected Kidney after Liver IR In sham-operated animals, plasma and tissue (liver and kidney) TNF-a, MCP-1, and ICAM-1 levels were very low or undetectable (Table 2 ). In contrast, plasma and liver TNF-a MCP-1 and ICAM-1 levels increased 5 and 24 h after liver IR in EGFP lentivirus-injected mice (Table 2 ). However, these increases at both 5 and 24 h were significantly attenuated in mice with unilateral renal injection of EGFP-huA 1 AR lentivirus and subjected to hepatic IR. Moreover, renal TNF-a increased 24 h after liver IR in EGFP lentivirus-injected mice, which was reduced in mice with unilateral renal injection of EGFP-huA 1 AR lentivirus and subjected to hepatic IR (Table 2) . We also measured the plasma cytokine levels in mice after removing the lentivirus-injected kidney and subjected to liver IR ( Table 2) . We show that mice subjected to unilateral nephrectomy and hepatic IR show increased plasma TNF-a, MCP-1, and ICAM-1 protein compared with mice with two intact kidneys (Table 2) . Furthermore, elimination of EGFP-huA 1 AR lentivirus-injected kidney abolishes the reductions in proinflammatory cytokines (TNF-a and MCP-1) and ICAM-1 in mice after liver IR (Table 2) .
Removing EGFP-huA 1 AR Lentivirus-Injected Kidney before Hepatic Ischemia Abolishes Both Renal and Hepatic Protection after Liver IR We tested whether removing the lentivurus injected kidney would impact renal and hepatic injury after liver IR. Unilateral nephrectomy of the EGFP lentivirus-injected kidney before hepatic ischemia did not significantly change the hepatic (ALT ¼ 15049 ± 1180 U/L, N ¼ 4) and renal injury (Cr ¼ 1.32 ± 0.15 mg/dl, N ¼ 4) compared with the EGFP lentivirus-injected mice with two intact kidneys ( Figure 3 ) 24 h after reperfusion. However, unilateral nephrectomy of the EGFP-huA 1 AR lentivirus-injected kidney before hepatic ischemia completely abolished the hepatic (
protective effects of renal huA 1 AR overexpression ( Figure 3) showing that the overexpression of huA 1 AR in the injected kidney has a crucial role in protecting the kidney and liver after liver IR. The ALT and Cr values in mice after EGFP or EGFP-huA 1 AR lentivirus injection and uninephrectomy alone were not different.
Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus Reduces Hepatic Necrosis after Liver IR Representative histological slides (magnification, Â 200 and Â 600) from liver tissues from mice renally injected with EGFP lentivirus or EGFP-huA 1 AR lentivirus and subjected to 60 min liver ischemia and 24 h reperfusion are shown in Figure 4 . Sixty minutes of partial hepatic IR produced large necrotic areas and vacuolization in the liver after reperfusion (Figure 4 ). Correlating with significantly improved function, reduced hepatic necrosis, and vacuolization were observed in mice renally injected with EGFPhuA 1 AR and subjected to hepatic IR ( Figure 4 ). We failed to detect necrosis in liver sections from sham-operated mice renally injected with EGFP or EGFP-huA 1 AR lentivirus (not shown). Livers were also analyzed for the degree of hepatocellular damage using Suzuki's criteria. 25 The ischemic lobes in the control group showed severe hepatocyte necrosis and sinusoidal congestion (Suzuki score ¼ 8.6 ± 0.5, N ¼ 5). Mice injected with EGFP-huA 1 AR revealed significantly less necrosis/sinusoidal congestion and better preservation of lobular architecture (Suzuki score ¼ 6.8±0.5, N ¼ 5, Po0.05). Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus Reduces Hepatic and Renal Neutrophil Infiltration 24 h after Liver IR Figure 6 shows representative images of neutrophil immunohistochemitry of liver (A, magnification Â 100) and kidney (B: injected kidney, magnification Â 400) from mice subjected to sham-operation or to 60 min of liver ischemia and 24 h reperfusion. Stained neutrophils seem dark brown. In sham-operated mice, we were unable to detect any neutrophils in liver or kidney. Sixty minutes of hepatic ischemia and 24 h reperfusion resulted in a heavy recruitment of Renal A 1 AR overexpression reduces hepatic and renal injury SW Park et al neutrophils into liver from mice renally injected with EGFP lentivirus (44±9 neutrophils/field, Â 100 magnification, N ¼ 6). Mice renally injected with EGFP-huA 1 AR lentivirus showed reduced number of neutrophils infiltrating the liver (13 ± 3 neutrophils/field, Â 100 magnification, N ¼ 6, Po0.01). Sixty minutes of hepatic ischemia also resulted in recruitment of neutrophils into kidney (Figure 6b ; injected kidney, magnification Â 400). Neutrophil infiltration 24 h after hepatic ischemia was significantly less in kidneys of mice renally injected with EGFP-huA 1 AR lentivirus compared with kidneys from mice renally injected with EGFP lentivirus and subjected to liver IR. Twenty-four hours after liver IR, we detected 14 ± 5 neutrophils/field ( Â 200 magnification, N ¼ 6) in kidney from mice renally injected with EGFP lentivirus and subjected to liver IR. The kidneys injected with EGFP-huA 1 AR lentivirus showed significantly reduced neutrophil infiltration 24 h after liver IR (2±1 neutrophils/ field, Â 200 magnification, N ¼ 6, Po0.05).
Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus Decreases Hepatic and Renal Vascular Permeability after Liver IR
We measured liver and kidney vascular permeability after liver IR with EBD injection. EBD binds to plasma proteins and its appearance in extravascular tissues reflects an increase in vascular permeability. Liver IR increased the EBD content in the liver for both groups, however, the increase in EBD content was significantly higher for the EGFP injected mice (478 ± 16 mg EBD per g dry liver, N ¼ 6) compared with the EGFP-huA 1 AR lentivirus-injected mice (348±17 mg EBD per g dry liver, N ¼ 6, Po0.01).
Liver IR also increased the EBD content in kidneys from both groups. However, the increase in EBD content was significantly higher for EGFP lentivirus renally injected kidney (95 ± 6 mg EBD per g dry kidney, N ¼ 6) compared with the EGFP-huA 1 AR lentivirus renally injected kidneys (71 ± 5 mg EBD per g dry kidney, N ¼ 6, Po0.01). Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus Reduces Hepatic and Renal Apoptosis after Liver IR We used three separate indices to detect apoptosis: TUNEL staining, DNA laddering, and caspase 3 fragmentation in mice renally injected with EGFP or EGFP-huA 1 AR lentivirus and subjected to 60 min liver ischemia and 24 h of reperfusion. Hepatic IR and 24 h of reperfusion 48 h after EGFP lentivirus injection resulted in significant apoptosis in liver and kidney. The TUNEL staining showed that endothelial cell apoptosis was predominant in kidney. Unilateral renal injection of EGFP-huA 1 AR lentivirus significantly reduced the apoptosis in liver and in lentivirus-injected kidney with reduced TUNEL staining (Figure 9 ), DNA laddering ( Figure 10 ), and caspase 3 fragmentation (Figure 11 ).
Unilateral Renal Injection of EGFP-huA 1 AR Lentivirus
Reduces the Degradation of Hepatic and Renal F-Actin after Liver IR Liver staining in sham-operated mice after injection with lentivirus encoding EGFP or EGFP-huA 1 AR shows localization of F-actin at the hepatocyte basolateral membranes and the bile canalicular membranes (Figure 12a ). As expected, 60 min of liver ischemia and 24 h of reperfusion resulted in severe disruption of liver parenchymal F-actin compared with the sham-operated mice (Figure 12a ; representative of six experiments) in mice renally injected with EGFP encoding lentivirus as the staining of basolateral hepatocyte membranes as well as bile canalicular membranes is strongly decreased and disorganized. However, mice renally injected with EGFP-huA 1 AR and subjected to liver IR show significantly better preserved F-actin structure after liver IR as staining is quite similar to that of sham-operated mice. Liver IR also resulted in a severe loss of F-actin in renal proximal tubules in 24 h. In Figure 12b epithelial cells are shown. Mice subjected to sham surgery showed intense stain in tubular epithelial cells and in the basal plasma membrane. In contrast, kidneys from mice renally injected with EGFP encoding lentivirus mice subjected to liver IR showed loss of F-actin staining in the tubular epithelial cells. However, mice renally injected with EGFP-huA 1 AR showed significantly better preserved F-actin structure after liver IR as the staining is quite similar to that of sham-operated mice. Mean flurorescent F-actin intensity showed reduced hepatocyte and renal proximal tubule F-actin degradation in mice renally injected with EGFPhuA 1 AR after liver IR (Figure 12c and f) . We also show that the mice renally injected with EGFP-huA 1 AR lentivirus show improved preservation of bile canalicular membrane F-actin number as well as fluorescent intensity (Figure 12d and e) . 13, 14 we determined whether EGFPhuA 1 AR lentivirus injection increases HSP27 mRNA as well as protein expression in the injected kidneys by performing RT-PCR and immunoblotting for mouse HSP27. Figure 13 shows that injection of EGFP-huA 1 AR lentivirus in mice resulted in increased HSP27 mRNA (A) and HSP27 protein (B) expression compared with EGFP lentivirus-injected mice kidneys 48 h after the transgene injection. We also examined the contralateral kidney (nonlentivirus-injected kidney) or liver and demonstrate that these organs failed to show enhanced HSP27 expression ( Figure 13 ). We also observed increased HSP27 protein expression (red fluorescence) detected with immunocytochemistry in EGFP-huA 1 AR lentivirus-injected mice kidney ( Figure 14) . Furthermore, we saw increased colocalization (yellow) of HSP27 (red fluorescence) and EGFP-A 1 AR (green fluorescence) in EGFP-huA 1 AR lentivirus-injected mice kidney.
DISCUSSION
The major finding of this study is that overexpression of cytoprotective huA 1 ARs in one kidney was sufficient to protect against liver and kidney injury after hepatic IR in vivo. We show that intraparenchymal injection of lentivirus preferentially expresses the transgene in the renal cortex and in the corticomedullary junction of the injected kidney. In mice renally injected with EGFP-huA 1 AR lentivirus, there were significant protections against renal apoptosis, reduced renal tubular necrosis, inflammation, apoptosis, F-actin degradation, and better preservation of the integrity of the vascular endothelium. Plasma and tissue (injected kidney and liver) levels of cytokines (TNF-a and MCP-1) and ICAM-1 were significantly lower in mice renally injected with EGFPhuA 1 AR lentivirus. Moreover mice injected with EGFPhuA 1 AR showed reduced liver necrosis, inflammation, apoptosis, and F-actin degradation after liver IR. Removing the lentivirus-injected kidney before hepatic ischemia abolished the protective effects of renal EGFP-huA 1 AR overexpression. Finally, we propose that the mechanism of improved renal and hepatic function after liver IR injury with intraparenchymal injection of EGFP-huA 1 AR lentivirus is through induction of HSP27. Therefore, intrarenal lentiviral delivery of A 1 ARs may potentially be used to protect against hepatic IR-induced kidney and liver injury.
Our previous studies showed that endogenous and exogenous A 1 AR activation produced renal protection in vivo and in vitro. 8, 9, 14, 26 Moreover, we recently showed that intrarenal injection of lentivirus encoding huA 1 AR not only produced robust receptor expression in the injected kidney but this selective renal expression of huA 1 ARs attenuated renal IR injury in mice lacking A 1 ARs. 13 We concluded from these previous studies that upregulation of huA 1 ARs in kidney is sufficient to produce increased cytoprotective signaling through activation of A 1 ARs with endogenously produced mouse adenosine. Taking these concepts further, the most significant finding of this study is that selective overexpression of huA 1 AR in one kidney was able to confer significant protection against both liver and kidney injury after hepatic IR in mice.
In this study, we show that renal injection of EGFPhuA 1 AR encoding lentivirus significantly reduced proximal tubule necrosis, vacuolization and simplification, and decreased the necrosis of liver parenchyma after liver IR. Furthermore, we show that overexpression of huA 1 AR in one kidney was able to suppress apoptotic cell death of the liver and the injected kidney after liver IR (reduced TUNEL staining, DNA laddering and caspase 3 fragmentation). Therefore, direct protection against renal injury with intrarenal injection of lentivirus encoding EGFP-huA 1 AR also protected against hepatic injury after liver IR. Necrotic liver cell death occurs directly by total breakdown of cellular homeostatic machinery secondary to massive depletion of ATP during and after the ischemic period. Necrosis also occurs during reperfusion where uncontrolled delivery of cytotoxic cytokines and/or free radicals cause further cellular derangements. 27 We believe the major changes in renal histology occur after reperfusion of the ischemic liver. The clinical significance of our finding is that the impairment in renal function after liver IR potentiates liver dysfunction in vivo and protecting the kidney can lead to liver protection after hepatic IR. The kidney, therefore, has an important role in modulating hepatic injury and necrosis after liver IR.
We achieved selective transduction of both EGFP and EGFP-huA 1 AR in the lentivirus-injected kidneys indicated by a lack of green fluorescence in the contralateral kidneys, heart, or lungs of mice renally injected with lentivirus. RT-PCR also showed that the injected transgene was concentrated within the cortices-injected kidney (Figure 1b) . We further confirmed the selective protein expression resulting from lentivirus injections by demonstrating that mice renally injected with EGFP-huA 1 AR lentivirus express huA 1 AR protein (immunocytochemistry; Figure 2 ) whereas mice injected with EGFP lentivirus do not. Therefore, our method of lentiviral gene delivery allowed us to directly test the hypothesis that overexpression of huA 1 AR expression in kidneys of mice through intrarenal injection improves renal function after liver IR injury. The expression of transgene (EGFP or EGFP-huA 1 AR) was observed primarily in the cortex and at the corticomedullary junction. At this site, there are primarily S3 segments of proximal tubule as the major tubular segment represented. Expression was nearly undetectable in the inner medulla where there is a concentration of collecting ducts and thin limbs of Henle. The major site of endothelial cell injury in our model of liver IR predominantly affects the 'outer stripe' of the outer medulla corresponding to the S3 segments of proximal tubule, which is located precisely at the corticomedullary junction. 28, 29 The production of several proinflammatory cytokines and adhesion molecules after hepatic IR contributes to the pathophysiology of liver injury. 1, 30 We show that as expected, all of the proinflammatory mRNAs examined (TNF-a KC, MCP-1, MIP-2, and ICAM-1) show enhanced expression in liver and kidney after hepatic IR. We also show that plasma and tissue (injected kidney and liver) levels of cytokines (TNF-a and MCP-1) and ICAM-1 were significantly lower in mice renally injected with EGFP-huA 1 AR lentivirus. TNF-a is a well known mediator of liver and kidney injury after IR. 31, 32 TNF-a is known to promote the migration of inflammatory cells into the renal parenchyma through the upregulation of MCP-1 and MIP-2 in kidney. 33 The CC chemokine MCP-1 and CXC chemokine MIP-2 are also important mediators in the pathogenesis of AKI. 34 Upregulation of MCP-1 and MIP-2 leads to neutrophil recruitment during AKI induced by renal IR or nephrotoxic agents. 35 Indeed, our study showed that liver IR not only caused rapid infiltration of neutrophils into liver but also caused neutrophil infiltration in kidney. The role of neutrophils in the pathophysiology of organ injury (including liver and kidney) is well recognized. 36 Overexpression of huA 1 AR in kidney was able to suppress several proinflammatory mRNAs (TNF-a, MCP-1, and ICAM-1) in liver and kidney. Furthermore, overexpression of huA 1 AR in kidney was able to suppress PMN infiltration in both liver and kidney with concomitant improvements in vascular endothelial cell integrity (indicated by reduced EBD infiltration).
Ischemia-reperfusion injury in vivo results in F-actin cytoskeleton degradation which further compromises organ function. 37, 38 For example, F-actin disruption is a well known stimulus of apoptosis in several cell lines. 39 We saw severe disruption of F-actin in liver and kidney proximal tubules after liver IR in EGFP lentivirus-injected mice. Specifically, we saw severe disruptions in both hepatocyte and bile canalicular F-actin cytoskeleton after liver IR ( Figure 11 ). Moreover, proximal tubule brush border F-actin was completely disrupted after liver IR ( Figure 11 ). We showed in this study that huA 1 AR overexpression in kidney resulted in markedly better preserved F-actin of liver and kidney. Intact F-actin cytoskeleton in liver and kidney of mice subjected to liver IR may have contributed to reduced necrosis and apoptosis observed in these mice. We showed in this study that intrarenal injection of EGFPhuA 1 AR lentivirus increased HSP27 mRNA and protein in the injected kidney only without increasing the HSP27 expression in the contralateral kidney or in the liver. We previously showed that A 1 AR activation led to the synthesis of new HSP27 in vitro 14 and in vivo. 40 Therefore, overexpression of EGFP-huA 1 AR in mice may produce renal protection through the induction of HSP27 in the injected kidneys. HSP27 is a member of family of chaperone proteins that are upregulated in response to a wide range of cellular stresses including hypoxia, ischemia, and exposure to toxic drugs. [41] [42] [43] [44] Increased expression of HSP27 serves to defend a cell against injury or death by acting as chaperones facilitating proper polypeptide folding and aberrant protein removal. [45] [46] [47] Furthermore, HSP27 is a potent anti-apoptotic protein and is a key stabilizer of the actin cytoskeleton; both of these cellular effects lead to increased resistance against cell death. [48] [49] [50] We previously showed that intrarenal injection of EGFP-huA 1 AR lentivirus in mice not only increased the HSP27 expression but also increased colocalization of HSP27 with F-actin in vivo. 13 Indeed, stress or injury in renal tubule cells promote association or colocalization of HSP27 with F-actin leading to cytoprotection in vitro. 51, 52 We propose that renal overexpression of huA 1 ARs led to increased HSP27 synthesis in the injected kidney with resultant F-actin stabilization with subsequent protection against AKI after liver IR.
We also show in this study that renal huA 1 AR overexpression is directly responsible for both hepatic and renal protection after liver IR in mice as removing the EGFPhuA 1 AR overexpressing kidney before liver IR completely abolished the hepatic and renal protective effects observed in these mice. Removing the lentivirus-injected kidney before β-Actin liver IR increased the plasma cytokine and ICAM-1 levels (Table 2) . Furthermore, removing the lentivirus-injected kidney before liver IR also abolished the reductions in plasma levels of cytokines and ICAM-1 in mice renally injected with EGFP-huA 1 AR lentivirus (Table 2) . Taken together, data from these cohorts of mice also confirm that systemic spill over of EGFP-huA 1 AR lentivirus (to contralateral kindey and/or to liver) cannot explain the hepatic and renal protective effects with EGFP-huA 1 AR lentivirus injection. Instead, we propose that direct EGFP-huA 1 AR-mediated reduction in AKI through HSP27 induction produced direct hepatic protection after IR. Our findings imply that liver IR-mediated AKI potentiates the liver injury further and protecting the kidney function causes reduction of liver damage after IR.
One of the limitations of the intraparenchymal injection of virus is that we cannot control the expression of the protective transgene in a specific cell type (eg, proximal tubule cells of the S3 segment). However, we show in this study that intraparenchymal injection of lentivirus encoding EGFPhuA 1 AR led to heavy expression in the cortex and proximal tubules. These are the areas that are the most susceptible to injury because of the precarious balance between oxygen supply and demand, high ATP consumption, and relatively low blood flow.
In summary, we show in this study that selective expression of huA 1 AR transgene in kidney is possible. We not only show renal protection but also observed improved liver function after intrarenal injection with huA 1 AR lentivirus in mice subjected to liver IR. Overexpression of huA 1 AR in the injected kidney was able to improve vascular integrity and reduce necrosis, apoptosis, and inflammation in both liver and kidney. We propose that huA 1 AR-mediated induction of HSP27 results in increased resistance against renal injury after liver IR leading to reduced liver injury as a consequence. HSP27 induction after huA 1 AR overexpression may reduce the necrotic, apoptotic, and inflammatory changes occurring in the injected kidney and liver providing overall renal and hepatic protection against liver IR. These findings may have important clinical implications as they imply that kidney-specific expression of A 1 ARs through lentiviral delivery is a viable therapeutic option in attenuating the effects of hepatic IR. 
